We thus reasoned that RTK signalling in GBM might also influence Rho/ROCK function through modulation of Rnd3 expression levels since Rnd3 has been shown to be moderately overexpressed in GBM and is a widely reported Rho/ROCK functional antagonist [22,23,34]. The gene discussed is RND3; the disease is glioblastoma.